Paul J. Mellett - 17 Jun 2022 Form 4 Insider Report for ENANTA PHARMACEUTICALS INC (ENTA)

Role
Treasurer and CFO
Signature
/s/ Nathaniel S. Gardiner as attorney-in-fact
Issuer symbol
ENTA
Transactions as of
17 Jun 2022
Net transactions value
+$40,960
Form type
4
Filing time
21 Jun 2022, 16:01:24 UTC
Previous filing
15 Feb 2022
Next filing
28 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENTA Common Stock Options Exercise $40,960 +3,480 +6% $11.77 61,558 17 Jun 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENTA Stock Option (right to buy) Options Exercise $0 -3,480 -100% $0.000000* 0 17 Jun 2022 Common Stock 3,480 $11.77 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the shares subject to the option are fully vested and exercisable.